# Neuranix S.r.l.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/neuranix-s-r-l

- Industry: Healthcare
- Headquarters: Napoli, Italy
- Website: www.neuranix.com
- Total disclosed funding: $2.1M
- Latest round: Seed (Jul 8, 2022)
- Investors on record: 2

## About

Based in Napoli, Italy, and founded in 2017 by Filip Moens (CEO), Biosline Holding, and Lorenzo Caporaletti, Neuranix S.r.l. operates as a healthcare company that develops and manufactures medical devices for people and pets with ear disorders. In July 2022, Neuranix S.r.l. raised EUR 2.1 million in seed funding from Bios Line Holding, with participation from CDP Venture Capital and individual investors also participating in the round.

Neuranix S.r.l. provides a medical device for two product families and pets to get hearing function measured in the outer ear and middle ear. The firm developed two devices namely vet-wave and med-wave. Vet-wave is developed for the veterinary field and is already in the international marketing phase. Med-wave is for ENT-related disorders.

The company plans to use the July 2022 funding to strengthen its organization, finance the process of go-to-market and prepare the launch of new PLAI technology-based products.

## Funding rounds

- Seed, Jul 8, 2022, $2.1M — CDP Venture Capital, Bios Line Holding

## Investors

- CDP Venture Capital (https://capitalatlas.ai/funds/cdp-venture-capital) — Seed
- Bios Line Holding — Seed